214 related articles for article (PubMed ID: 28856551)
21. Immunization attitudes and practices among family medicine providers.
Bonville CA; Domachowske JB; Cibula DA; Suryadevara M
Hum Vaccin Immunother; 2017 Nov; 13(11):2646-2653. PubMed ID: 29028414
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.
Iversen OE; Miranda MJ; Ulied A; Soerdal T; Lazarus E; Chokephaibulkit K; Block SL; Skrivanek A; Nur Azurah AG; Fong SM; Dvorak V; Kim KH; Cestero RM; Berkovitch M; Ceyhan M; Ellison MC; Ritter MA; Yuan SS; DiNubile MJ; Saah AJ; Luxembourg A
JAMA; 2016 Dec; 316(22):2411-2421. PubMed ID: 27893068
[TBL] [Abstract][Full Text] [Related]
23. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes.
Kahn JA; Zimet GD; Bernstein DI; Riedesel JM; Lan D; Huang B; Rosenthal SL
J Adolesc Health; 2005 Dec; 37(6):502-10. PubMed ID: 16310128
[TBL] [Abstract][Full Text] [Related]
24. Primary care team- and clinic level factors affecting HPV vaccine uptake.
Chuang E; Cabrera C; Mak S; Glenn B; Hochman M; Bastani R
Vaccine; 2017 Aug; 35(35 Pt B):4540-4547. PubMed ID: 28736202
[TBL] [Abstract][Full Text] [Related]
25. The content and context of physicians' communication with males about human papillomavirus vaccination.
Malo TL; Ali KN; Sutton SK; Perkins RB; Giuliano AR; Vadaparampil ST
Hum Vaccin Immunother; 2016 Jun; 12(6):1511-8. PubMed ID: 26835599
[TBL] [Abstract][Full Text] [Related]
26. The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations.
Moghtaderi A; Adams S
Appl Health Econ Health Policy; 2016 Jun; 14(3):349-59. PubMed ID: 26873090
[TBL] [Abstract][Full Text] [Related]
27. Human Papillomavirus Vaccine Coverage and Prevalence of Missed Opportunities for Vaccination in an Integrated Healthcare System.
Irving SA; Groom HC; Stokley S; McNeil MM; Gee J; Smith N; Naleway AL
Acad Pediatr; 2018 Mar; 18(2S):S85-S92. PubMed ID: 29502643
[TBL] [Abstract][Full Text] [Related]
28. Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines.
Van Damme P; Bonanni P; Bosch FX; Joura E; Kjaer SK; Meijer CJ; Petry KU; Soubeyrand B; Verstraeten T; Stanley M
Vaccine; 2016 Feb; 34(6):757-61. PubMed ID: 26772631
[TBL] [Abstract][Full Text] [Related]
29. Cancer Prevention Education for Providers, Staff, Parents, and Teens Improves Adolescent Human Papillomavirus Immunization Rates.
Suryadevara M; Bonville CA; Cibula DA; Domachowske JB
J Pediatr; 2019 Feb; 205():145-152.e2. PubMed ID: 30314663
[TBL] [Abstract][Full Text] [Related]
30. Providers' practice, recommendations and beliefs about HPV vaccination and their adherence to guidelines about the use of HPV testing, 2007 to 2010.
Berkowitz Z; Nair N; Saraiya M
Prev Med; 2016 Jun; 87():128-131. PubMed ID: 26921654
[TBL] [Abstract][Full Text] [Related]
31. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.
Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S
Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142
[TBL] [Abstract][Full Text] [Related]
32. Association of physicians perceived barriers with human papillomavirus vaccination initiation.
Farias AJ; Savas LS; Fernandez ME; Coan SP; Shegog R; Healy CM; Lipizzi E; Vernon SW
Prev Med; 2017 Dec; 105():219-225. PubMed ID: 28834689
[TBL] [Abstract][Full Text] [Related]
33. HPV Vaccine Delivery Practices by Primary Care Physicians.
Kempe A; O'Leary ST; Markowitz LE; Crane LA; Hurley LP; Brtnikova M; Beaty BL; Meites E; Stokley S; Lindley MC
Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31527175
[TBL] [Abstract][Full Text] [Related]
34. Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents.
Mohammed KA; Geneus CJ; Osazuwa-Peters N; Adjei Boakye E; Tobo BB; Burroughs TE
J Adolesc Health; 2016 Nov; 59(5):592-598. PubMed ID: 27506278
[TBL] [Abstract][Full Text] [Related]
35. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
Petrosky E; Bocchini JA; Hariri S; Chesson H; Curtis CR; Saraiya M; Unger ER; Markowitz LE;
MMWR Morb Mortal Wkly Rep; 2015 Mar; 64(11):300-4. PubMed ID: 25811679
[TBL] [Abstract][Full Text] [Related]
36. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
[TBL] [Abstract][Full Text] [Related]
37. Human Papillomavirus Infection and Vaccination.
Valentino K; Poronsky CB
J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
[TBL] [Abstract][Full Text] [Related]
38. Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis.
Laprise JF; Markowitz LE; Chesson HW; Drolet M; Brisson M
J Infect Dis; 2016 Sep; 214(5):685-8. PubMed ID: 27234416
[TBL] [Abstract][Full Text] [Related]
39. Human Papillomavirus Vaccine: Continuation, Completion, and Missed Opportunities.
Richards MJ; Peters M; Sheeder J
J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):117-21. PubMed ID: 26300233
[TBL] [Abstract][Full Text] [Related]
40. Factors Associated with Increased HPV Vaccine Use in Rural-Frontier U.S. States.
Lai D; Ding Q; Bodson J; Warner EL; Kepka D
Public Health Nurs; 2016 Jul; 33(4):283-94. PubMed ID: 26331614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
